miR-30 靶向调控 Zeb2 相关通路抑制胆囊癌细胞 EMT 进程
作者:
作者单位:

1.新疆维吾尔自治区肿瘤医院肝胆胰外科,乌鲁木齐 830000;2.新疆医科大学第二附属医院康复科,乌鲁木齐 830000

中图分类号:

R-33


miR-30 inhibits EMT of gallbladder cancer cells via Zeb2-related pathways
Author:
Affiliation:

1.Department of Hepatobiliary and Pancreatic Surgery, Xinjiang Cancer Hospital, Urumqi 830000, China.2. Department of Rehabilitation, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830000

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • | |
  • 文章评论
    摘要:

    目的 本研究旨在探讨小 RNA-30(miR-30)在胆囊癌(GBC)上皮间充质转化(EMT)进程中的作用和潜在机制。 方法 qRT-PCR 用于检测胆囊上皮细胞和癌细胞系 miR-30 相对表达水平;过表达 miR-30 后采用MTT、平板克隆实验用于检测细胞增殖能力;细胞划痕实验和 Transwell 小室试验分别评估细胞迁移和侵袭能力;Western blot 用于评估细胞 EMT 相关蛋白(E-cadherin、N-cadherin 和 Vimentin)和 EMT 相关转录因子( Snail、Slug 和Zeb2)的表达水平。 拯救实验用于探索 miR-30 与 Zeb2 的靶向调控关系。 结果 miR-30 在 2 个代表性 GBC 细胞系(GBC-SD 和 NOZ)中明显下调(P<0. 05)。 过表达 miR-30 会抑制 GBC-SD 细胞增殖、克隆形成、细胞迁移、细胞侵袭和 EMT 过程(P<0. 05),而过表达 Zeb2 可以逆转 miR-30 导致的 EMT 抑制作用(P<0. 05)。 结论 miR-30 通过靶向 Zeb2 减弱 GBC 细胞的 EMT 进展,表明 miR-30 是一种肿瘤抑制因子,可作为 GBC 的新型潜在分子治疗靶点。

    Abstract:

    Objective This study aimed to explore the role and potential mechanism of miR-30 in EMT of gallbladder cancer ( GBC). Methods qRT-PCR was used to measure the relative expression level of miR-30 in gallbladder epithelial cells and cancer cell lines. After overexpression of miR-30, MTT and colony formation assays were used to assess cell proliferation. Wound healing and Transwell assays were used to evaluate cell migratory and invasive abilities, respectively. Western blot was used to evaluate the expression levels of EMT-related proteins (E-cadherin, Ncadherin and Vimentin) and EMT-related transcription factors (Snail, Slug and Zeb2). A rescue experiment was carried to explore the regulatory relationship between miR-30 and Zeb2. Results miR-30 was significantly downregulated in two representative GBC cell lines ( GBC-SD and NOZ) ( P< 0.05). Overexpression of miR-30 inhibited GBC-SD cell proliferation, colony formation, migration, invasion and EMT ( P< 0.05). Overexpression of Zeb2 reverses the EMT inhibitory effect caused by miR-30 (P<0.05). Conclusions miR-30 attenuates EMT of GBC cells by targeting Zeb2,which indicates that miR-30 is a tumor suppressor and can be used as a novel therapeutic target for GBC.

    参考文献
    相似文献
    引证文献
引用本文

唐津天,唐润娟. miR-30 靶向调控 Zeb2 相关通路抑制胆囊癌细胞 EMT 进程[J].中国比较医学杂志,2022,32(9):69~75.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-12-09
  • 在线发布日期: 2023-01-16
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭